119 related articles for article (PubMed ID: 21833473)
1. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
Taniuchi K; Iwasaki S; Saibara T
Int J Oncol; 2011 Nov; 39(5):1243-52. PubMed ID: 21833473
[TBL] [Abstract][Full Text] [Related]
2. BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
Taniuchi K; Yokotani K; Saibara T
Neoplasia; 2012 May; 14(5):440-50. PubMed ID: 22745590
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the ARL2-GTP-BART complex reveals a novel recognition and binding mode of small GTPase with effector.
Zhang T; Li S; Zhang Y; Zhong C; Lai Z; Ding J
Structure; 2009 Apr; 17(4):602-10. PubMed ID: 19368893
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis.
Kusama T; Mukai M; Endo H; Ishikawa O; Tatsuta M; Nakamura H; Inoue M
Cancer Sci; 2006 Sep; 97(9):848-53. PubMed ID: 16776779
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal domain of G3BP enhances cell motility and invasion by posttranscriptional regulation of BART.
Taniuchi K; Nishimori I; Hollingsworth MA
Mol Cancer Res; 2011 Jul; 9(7):856-66. PubMed ID: 21665939
[TBL] [Abstract][Full Text] [Related]
6. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells.
Yoshioka K; Nakamori S; Itoh K
Cancer Res; 1999 Apr; 59(8):2004-10. PubMed ID: 10213513
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
[TBL] [Abstract][Full Text] [Related]
9. Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.
Taniuchi K; Nishimori I; Hollingsworth MA
Cancer Res; 2011 Feb; 71(3):895-905. PubMed ID: 21266361
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K
Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181
[TBL] [Abstract][Full Text] [Related]
11. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG
EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
[TBL] [Abstract][Full Text] [Related]
13. The ARF-like 2 (ARL2)-binding protein, BART. Purification, cloning, and initial characterization.
Sharer JD; Kahn RA
J Biol Chem; 1999 Sep; 274(39):27553-61. PubMed ID: 10488091
[TBL] [Abstract][Full Text] [Related]
14. Regulator of G-protein signalling 3 redirects prototypical Gi-coupled receptors from Rac1 to RhoA activation.
Vogt A; Lutz S; Rümenapp U; Han L; Jakobs KH; Schmidt M; Wieland T
Cell Signal; 2007 Jun; 19(6):1229-37. PubMed ID: 17300916
[TBL] [Abstract][Full Text] [Related]
15. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
16. A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival.
Moorman JP; Luu D; Wickham J; Bobak DA; Hahn CS
Oncogene; 1999 Jan; 18(1):47-57. PubMed ID: 9926919
[TBL] [Abstract][Full Text] [Related]
17. Carbon-Ion Irradiation Suppresses Migration and Invasiveness of Human Pancreatic Carcinoma Cells MIAPaCa-2 via Rac1 and RhoA Degradation.
Fujita M; Imadome K; Shoji Y; Isozaki T; Endo S; Yamada S; Imai T
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):173-80. PubMed ID: 26279033
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
19. The structure of binder of Arl2 (BART) reveals a novel G protein binding domain: implications for function.
Bailey LK; Campbell LJ; Evetts KA; Littlefield K; Rajendra E; Nietlispach D; Owen D; Mott HR
J Biol Chem; 2009 Jan; 284(2):992-9. PubMed ID: 18981177
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of myometrial RHO effector proteins (PKN1 and DIAPH1) and CPI-17 (PPP1R14A) phosphorylation in human pregnancy is associated with increased GTP-RHOA in spontaneous preterm labor.
Lartey J; Smith M; Pawade J; Strachan B; Mellor H; López Bernal A
Biol Reprod; 2007 Jun; 76(6):971-82. PubMed ID: 17301291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
